
Lupin shares rise 2% on launching heart drug in Canada
The pharma major’s subsidiary has launched Propranolol LA capsules, 60 mg, 80 mg, 120 mg, and 160 mg, in Canada.
The pharma major’s subsidiary has launched Propranolol LA capsules, 60 mg, 80 mg, 120 mg, and 160 mg, in Canada.
The FDA asks the company to "correct any violations promptly", failing which the global agency may withhold approval of new applications or supplements listing
The scrip opened a gap-up at ₹834.95 on Wednesday against the closing price of the previous session at ₹829.65.
From June 1, 2023, cough syrup will be permitted to be exported only after testing and production of certificate issued by govt labs
The federal agency has put on hold the trial of 12 mg of Deuruxolitinib clinical trial owing to a potential pulmonary embolism.
The U.S. drug regulator has issued Form 483 with ten observations for Lupin’s Pithampur unit-2 manufacturing facility.
Lupin Pharmaceuticals Inc., the U.S. arm of the drug major, is voluntarily recalling four lots of Quinapril Tablets due to the presence of nitrosamine impurity.
The pharma company received a warning letter from the U.S. FDA for violations of manufacturing standards at the Halol facility in Gujarat.
The U.S. drug regulator has pointed out various lapses at Glenmark Pharma’s Goa facility, which produces drug formulations.
Affected products are produced under Unilever brands like Dove, Nexxus, Suave, TIGI and TRESemmé. Unilever’s Indian unit HUL says it doesn’t make dry shampoos in India.